Literature DB >> 18336058

Assessing the efficacy of treatments for ADHD : overview of methodological issues.

Vishal Madaan1, Joan Daughton, Brian Lubberstedt, Andy Mattai, Brigette S Vaughan, Christopher J Kratochvil.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common and impairing psychiatric condition that affects significant numbers of children, adolescents and adults. Clinicians in a variety of practice settings (hospital, outpatient, residential, research) strive to diagnose, treat and monitor ADHD in an efficient and evidence-based manner. Tools that facilitate the gathering and interpretation of information from a variety of sources can effectively augment a diagnostic assessment, and can also be useful for longitudinal monitoring. Multiple assessment tools are available, with varying degrees of psychometric validity, clinical utility and overall feasibility (time and cost). This review provides an overview of several available ADHD rating scales and continuous performance tests, and offers a discussion of potential strengths and weaknesses of the instruments. While these tools do not in and of themselves make a diagnosis of ADHD, they can certainly assist in the diagnostic assessment, be crucial in assessing the efficacy of medications in clinical trials, and be a useful adjunct in the clinical management of ADHD.

Entities:  

Mesh:

Year:  2008        PMID: 18336058     DOI: 10.2165/00023210-200822040-00002

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  34 in total

1.  ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument.

Authors:  S Zhang; D E Faries; M Vowles; D Michelson
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

2.  Reliability and validity of the SKAMP rating scale in a laboratory school setting.

Authors:  S B Wigal; S Gupta; D Guinta; J M Swanson
Journal:  Psychopharmacol Bull       Date:  1998

3.  A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.

Authors:  S R Pliszka; R G Browne; R L Olvera; S K Wynne
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-05       Impact factor: 8.829

4.  A teacher rating scale for use in drug studies with children.

Authors:  C K Conners
Journal:  Am J Psychiatry       Date:  1969-12       Impact factor: 18.112

5.  Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.

Authors:  L L Greenhill; J M Swanson; B Vitiello; M Davies; W Clevenger; M Wu; L E Arnold; H B Abikoff; O G Bukstein; C K Conners; G R Elliott; L Hechtman; S P Hinshaw; B Hoza; P S Jensen; H C Kraemer; J S March; J H Newcorn; J B Severe; K Wells; T Wigal
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

6.  Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Authors:  J M Swanson; H C Kraemer; S P Hinshaw; L E Arnold; C K Conners; H B Abikoff; W Clevenger; M Davies; G R Elliott; L L Greenhill; L Hechtman; B Hoza; P S Jensen; J S March; J H Newcorn; E B Owens; W E Pelham; E Schiller; J B Severe; S Simpson; B Vitiello; K Wells; T Wigal; M Wu
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

Review 7.  Review of clinical validation of ADHD behavior rating scales.

Authors:  Steven M Snyder; James R Hall; Sonya L Cornwell; Humberto Quintana
Journal:  Psychol Rep       Date:  2006-10

Review 8.  Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents.

Authors:  William E Pelham; Gregory A Fabiano; Greta M Massetti
Journal:  J Clin Child Adolesc Psychol       Date:  2005-09

9.  Child global rating scales: selecting a measure of client functioning in a large mental health system.

Authors:  J L Sorensen; W A Hargreaves; S Friedlander
Journal:  Eval Program Plann       Date:  1982

10.  Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales.

Authors:  James M Swanson; Sabrina Schuck; Miranda Mann Porter; Caryn Carlson; Catharina A Hartman; Joseph A Sergeant; Walter Clevenger; Michael Wasdell; Richard McCleary; Kimberley Lakes; Timothy Wigal
Journal:  Int J Educ Psychol Assess       Date:  2012-04
View more
  3 in total

1.  Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review.

Authors:  Jeffery N Epstein; Margaret D Weiss
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-29

2.  Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months.

Authors:  Liang-Jen Wang; Yu-Shu Huang; Yuan-Lin Chiang; Chen-Cheng Hsiao; Zong-Yi Shang; Chih-Ken Chen
Journal:  BMC Psychiatry       Date:  2011-04-19       Impact factor: 3.630

3.  Potential role of pre- and postnatal testosterone levels in attention-deficit/hyperactivity disorder: is there a sex difference?

Authors:  Liang-Jen Wang; Miao-Chun Chou; Wen-Jiun Chou; Min-Jing Lee; Sheng-Yu Lee; Pao-Yen Lin; Yi-Hsuan Lee; Yi-Hsin Yang; Cheng-Fang Yen
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-16       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.